Treatment of Non-alcoholic Steatohepatitis (NASH) Patients With Vitamin D

Phase 2

Completed

• Conditions: Non-alcoholic Steatohepatitis (NASH)
• Interventions: Drug: Vitamin D3; Drug: Placebo

• Registration Number: NCT01571063
• Lead Sponsor: University of Zurich

Brief Summary

Test the efficacy of vitamin D to improve non-alcoholic steatohepatitis with regard to biochemical and histological parameters.

* Trial with medicinal product

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2012-03-28
• Study First Submitted QC: 2012-04-02
• Study First Posted: 2012-04-04
• Study Start: 2013-01
• Primary Completion: 2016-05
• Study Completion: 2016-05
• Status Verified: 2016-10
• Last Update Submitted: 2016-10-24
• Last Update Posted: 2016-10-25

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 22

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Vitamin D3	Placebo	-
Placebo	Placebo	-
Vitamin D3	Vitamin D3	-
Placebo	Vitamin D3	-

Primary Outcome Measures

Name	Time	Method
Change from Baseline in serum alanine aminotransferase levels at week 48	Measurement at week 0 and week 48

Trial Locations

Locations (2)

University Hospital Zurich, Gastroenterology and Hepatology; 🇨🇭 Zurich, ZH, Switzerland

Kantonsspital St. Gallen; 🇨🇭 St. Gallen, Switzerland